Celyad SA is a biopharmaceutical company. The Company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.
| Website: | www.c3bs.com |
| Main Phone: | +32 10394100 |
| Address: | Rue Edouard Belin 12 |
| City / Town: | Mont-Saint-Guibert |
| Country: | BEL |
| Postal Code: | 1435 |
| Exchange: | NSD |
| Employees: | 88 |
| Last Price 44.27 | Change $ 0. | Change % 0.00 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open N/A | High N/A | Low N/A | Prev Close 44.27 |
| Last Trade | Volume 41 | 52 Wk Hi 48.93 | 52 Wk Low 16.31 |
| Market Cap 421.5 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 9,520,853.00 | EPS (TTM) -2.66 | PE Ratio N/A | Exchange NSD |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 75 | 75 | 75 | 75 |
| Low Target Price Estimate | 27 | 27 | 27 | 27 |
| Mean Target Price Estimate | 49 | 49 | 49 | 49 |
| Standard Deviation | 24.25 | 24.25 | 24.25 | 24.25 |
| Date of Most Recent Estimate | 07/04/16 | 07/04/16 | 07/04/16 | 08/25/16 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.5 | 1.5 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
